OALib Journal期刊
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
DOI: 10.1080/2162402X.2015.1136044
Adi Diab ,
Alexandre Reuben ,
Arlene H. Sharpe ,
Cara Haymaker ,
Christine N. Spencer ,
Dennie T. Frederick ,
Edwin R. Parra ,
Hong Jiang ,
Ignacio I. Wistuba ,
Isabella C. Glitza ,
Jacob L. Austin-Breneman ,
Jaime Rodriguez-Canales ,
James P. Allison ,
Jeffrey E. Gershenwald ,
Jennifer A. Wargo ,
Karen Clise-Dwyer ,
Keith T. Flaherty ,
Lisa M. Coussens ,
Luis M. Vence ,
Lynda Chin ,
Michael A. Davies ,
Michael T. Tetzlaff ,
Padmanee Sharma ,
Patrick Hwu ,
Peter A. Prieto ,
Rodabe N. Amaria ,
Ryan J. Sullivan ,
Sapna P. Patel ,
Scott E. Woodman ,
Vancheswaran Gopalakrishnan ,
Zachary A. Cooper Keywords: Immune checkpoint blockade , melanoma , targeted therapy , BRAF , CTLA-4 , PD-1
Abstract:
Full-Text
Contact Us
service@oalib.com
QQ:3279437679
WhatsApp +8615387084133
